ACADIA Pharmaceuticals (NASDAQ:ACAD) CFO Thomas Aasen sold 15,000 shares of ACADIA Pharmaceuticals stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $22.48, for a total value of $337,200.00. Following the completion of the sale, the chief financial officer now directly owns 23,848 shares of the company’s stock, valued at approximately $536,103. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares after opening at $17.87 moved to $18.36 on last trade day and at the end of the day closed at $18.36. Company price to sales ratio in past twelve months was calculated as 1643.39 and price to cash ratio as 9.73. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) showed a negative weekly performance of -12.53%.
Zebra Technologies Corporation and Motorola Solutions have announced that they have entered into a definitive agreement in which Zebra will acquire Motorola’s Enterprise business for $3.45 billion in an all-cash transaction. The acquisition will be funded through a combination of cash on hand and new debt. The transaction, which was approved by the Boards of Directors of both companies, is subject to customary closing conditions including regulatory approvals. The transaction is expected to be completed by the end of 2014. Zebra Technologies Corp. (NASDAQ:ZBRA) shares fell -10.09% in last trading session and ended the day on $61.39. ZBRA return on equity ratio is recorded as 14.70% and its return on assets is 12.90%. Zebra Technologies Corp. (NASDAQ:ZBRA) yearly performance is 35.31%.
Incyte (NASDAQ:INCY)‘s stock had its “neutral” rating reiterated byZacks in a research report issued on Thursday, Analyst Ratings.Net reports. They currently have a $55.00 target price on the stock. Zacks‘s price target would indicate a potential upside of 18.92% from the stock’s previous close. Incyte Corporation (NASDAQ:INCY) shares moved down -2.75% in last trading session and was closed at $43.10, while trading in range of $40.30-$44.69. Incyte Corporation (NASDAQ:INCY) year to date performance is -14.87%.
Mattson Technology, Inc. (NASDAQ:MTSN), a leading supplier of advanced process equipment used to manufacture semiconductors, announced that the company will host a conference call on Thursday, April 24, 2014 at 6:00 p.m. Eastern Time (3:00 p.m. Pacific Time). The conference call will cover 2014 first quarter financial results and current business conditions. Mattson Technology, Inc. (NASDAQ:MTSN) weekly performance is -18.70%. On last trading day company shares ended up $2.00. Mattson Technology, Inc. (NASDAQ:MTSN) distance from 50-day simple moving average is -21.11%. Analysts mean target price for the company is $3.75.